Parkinson's Disease

This hub offers a comprehensive exploration of Parkinson’s disease, integrating the latest scientific understanding, clinical practice, and emerging research. The linked articles cover the fundamentals of Parkinson’s disease pathophysiology, diagnosis, treatment strategies, and prognosis, while also examining associated conditions, genetic factors, and disease-modifying therapies. Readers will find evidence-based guidance on symptom management, including motor and non-motor features, along with in-depth discussions on neuroprotective interventions, the gut-brain axis, and the role of comorbidities. The collection also addresses the psychosocial impact of Parkinson’s disease, support resources, and advances in experimental therapies. Whether you are a healthcare professional, researcher, patient, or caregiver, these resources provide authoritative insights into the complex landscape of Parkinson’s disease.

Does Exercise Slow Parkinson's Disease Progression?

A growing pool of evidence suggests that high-intensity physical exercise may have beneficial outcomes in PD patients.

VPS35 Gene and Parkinson's Disease

Parkinson’s Disease and Sleeping Disorders

Herpes Virus and Parkinson's Disease

Parkinson's Disease Prognosis

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Identifying Early Symptoms in Parkinson’s

Parkinson's Disease History

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

Parkinson's Disease and Helicobacter Pylori

Parkinson's Disease Treatment

Physiotherapy for Parkinson's Disease

See more featured articles »

Parkinson's Disease Support

Parkinson's Disease Diagnosis

Parkinson's Disease and the Gut Microbiome

Gene Therapies for Parkinson’s Disease

Parkinson's Disease Pathophysiology

Human brain may stay active for hours after death

Estrogen as a Treatment for Parkinson’s Disease

Is Appendectomy Linked to Parkinson’s Disease?

Bipolar Disorder and Parkinson’s

Parkinson's Disease Research

Developing Drugs for Neurodegenerative Diseases

Impact of COVID-19 on Parkinson's Disease

Thalamotomy, Pallidotomy and Subthalamotomy

What is Parkinson's Disease?

Where Does Parkinson’s Disease Originate?

Progressive Supranuclear Palsy (PSP) Versus Parkinson's Disease

Gut-Brain Axis and Neurodegenerative Disorders

Uncovering Hidden Symptoms: Hallucinations and Delusions in Parkinson’s Disease

Gut Bacteria Affecting Parkinson’s Treatment

Mythbusting: Misconceptions surrounding Parkinson’s Disease

Neurophysiotherapy for Parkinson's Disease

Parkinsonism in Spinocerebellar Ataxia

Latest Parkinson's Disease News and Research

Unraveling the brain mechanisms behind social hierarchies in mice

Social hierarchies are everywhere-think of high school dramas, where the athletes are portrayed as most popular, or large companies, where the CEO makes the important decisions.

7 Oct 2025

Scientists directly visualize protein clusters linked to Parkinson’s for the first time

Scientists have, for the first time, directly visualized and quantified the protein clusters believed to trigger Parkinson's, marking a major advance in the study of the world's fastest-growing neurological disease.

2 Oct 2025

Long-term exposure to industrial solvent associated with elevated Parkinson's disease risk

Long-term exposure to the industrial solvent trichloroethylene (TCE) outdoors may be linked to an increased risk of Parkinson's disease, according to a large nationwide study published in the October 1, 2025, issue of Neurology, the medical journal of the American Academy of Neurology.

2 Oct 2025

Optogenetics and artificial intelligence open path to personalized Parkinson’s treatment

Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents a complex set of motor symptoms, including tremors, rigidity, bradykinesia, and postural instability.

26 Sep 2025

Breakthrough in predicting Parkinson’s and dementia in people with REM sleep behavior disorder

An international research team led by Université de Montréal medical professor Shady Rahayel has made a major breakthrough in predicting neurodegenerative diseases.

26 Sep 2025

Scientists explore how dopamine shapes myelin in social isolation

Scientists know that social isolation can alter brain structure and lead to the breakdown of myelin, the fatty coating that insulates nerve fibers in the brain. But they don't yet know exactly how or why it happens.

25 Sep 2025

UdeM studies make a major breakthrough in predicting neurodegenerative diseases

An international research team led by Université de Montréal medical professor Shady Rahayel has made a major breakthrough in predicting neurodegenerative diseases.

25 Sep 2025

COVID-19 linked to long-lasting reductions in smell even without noticeable symptoms

People who suspect that their sense of smell has been dulled after a bout of COVID-19 are likely correct, a new study using an objective, 40-odor test shows. Even those who do not notice any olfactory issues may be impaired.

25 Sep 2025

AstroCapsules offer a new way to reduce brain inflammation

Neuroinflammation is linked to a host of detrimental brain disorders, including Alzheimer's and Parkinson's disease.

25 Sep 2025

Scientists map step-by-step activation of brain receptors

When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, know that even slight changes in their activity level can mean the difference between normal function and serious neurological disorders.

24 Sep 2025

Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease

A new Lancet review proposes a three-wave diagnostic pathway that combines clinical expertise with blood, CSF, and PET biomarkers. This approach aims to deliver earlier, more accurate, and more equitable Alzheimer’s disease diagnosis worldwide.

24 Sep 2025

Stem cell therapy restores brain function after stroke

Stem cell transplantation can reverse stroke damage, researchers at the University of Zurich report. Its beneficial effects include regeneration of neurons and restoration of motor functions, marking a milestone in the treatment of brain disorders.

16 Sep 2025

Age influences amyloid positivity in Parkinson's disease without dementia

A new research paper was published in Volume 17, Issue 8 of Aging-US on August 6, 2025, titled "Age-related trends in amyloid positivity in Parkinson's disease without dementia."

16 Sep 2025

AI spots movement alterations before Parkinson’s symptoms appear

Early detection of even the slightest motor function changes can be critical to slowing the progression of Parkinson's disease. Yet these subtle signs often go unnoticed.

10 Sep 2025

Bee-sting inspired microneedle patches offer pain-free drug delivery

Neurological diseases affect millions worldwide, and the need for long-term patient-friendly treatments has never been greater.

10 Sep 2025

Ultrasound device enables precise non-invasive stimulation of deep brain regions

An ultrasound device that can precisely stimulate areas deep in the brain without surgery has been developed by researchers from UCL and the University of Oxford, opening up new possibilities for neurological research and treatment of disorders such as Parkinson's disease.

5 Sep 2025

Study finds possible molecular connection between air pollution and Lewy body dementia risk

A team of researchers found there is a possible molecular connection between air pollution and an increased risk of developing Lewy body dementia.

4 Sep 2025

Prefrontal cortex biopsies during deep brain stimulation surgery do not increase risk of adverse events

Obtaining prefrontal cortex biopsies during deep brain stimulation (DBS) surgery in living patients does not increase the risk of adverse events or cognitive decline compared to standard DBS procedures that don't involve biopsies, a team of clinical research scientists at the Icahn School of Medicine at Mount Sinai has demonstrated.

4 Sep 2025

New Mohn Research Center aims to protect the brain and prevent Parkinson’s disease

Backed by NOK 50 million (~USD 5 million) from the Mohn Foundation in partnership with the University of Bergen (UiB) and Haukeland University Hospital, the Center will unite clinicians, neuroscientists, and data experts to understand who is at risk, how disease begins, and how to protect the brain before irreversible damage occurs.

4 Sep 2025

New neurochemical signature distinguishes Parkinson’s disease from essential tremor

Researchers have identified a neurochemical signature that sets Parkinson's disease apart from essential tremor - two of the most common movement disorders, but each linked to distinct changes in the brain.

2 Sep 2025